Back
JPMorgan Chase & Co. Vs. Summit Therapeutics Industry Stock Comparison
Buy
56
JPM
JPMorgan Chase & Co.
Last Price:
$293.88
Seasonality Move:
-0.29%
Sell
44
SMMT
Summit Therapeutics
Last Price:
$26.44
Seasonality Move:
7.77%
Buy
56
JPMorgan Chase & Co. (JPM)
is a Buy
Is JPMorgan Chase & Co. a Buy, Sell or Hold?
-
The current JPMorgan Chase & Co. [JPM] share price is $294.16. The Score for JPM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
JPM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $26.45. The Score for SMMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JPM Stock Price Chart
What is JPMorgan Chase & Co.'s stock price today?
-
The JPMorgan Chase & Co. share price today is $294.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.45The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
JPM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 73.84 | Buy |
Relative Strength Index (14 RSI): | 55.91 | Buy |
Chaikin Money Flow: | 6211484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.87 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | -2954339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
JPM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 290.69 | Buy |
20-day SMA: | 293.3 | Buy |
50-day SMA: | 285.1 | Buy |
200-day SMA: | 257.2 | Buy |
8-day EMA: | 280.56 | Buy |
20-day EMA: | 212.45 | Buy |
50-day EMA: | 118.5 | Buy |
200-day EMA: | 35.64 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.7 | Sell |
20-day SMA: | 27.43 | Sell |
50-day SMA: | 24.26 | Buy |
200-day SMA: | 21.71 | Buy |
8-day EMA: | 26.19 | Buy |
20-day EMA: | 19.98 | Buy |
50-day EMA: | 11.15 | Buy |
200-day EMA: | 3.35 | Buy |
JPMorgan Chase & Co. Earnings Growth & JPM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.52 per share, an increase this year of $0.95 per share, and an increase next year of $1.26 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.33 per share, and an increase next year of $0.06 per share.
JPMorgan Chase & Co. Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |